G1P1 (1001) complete abortion, myoma, multiple - Nursing Case Study

Pathophysiology

• Primary mechanism: In a complete abortion, the body expels all pregnancy tissue from the uterus. This process involves uterine contractions and cervical dilation, leading to the complete removal of the embryo or fetus and placenta, typically occurring within the first 20 weeks of gestation.

• Secondary mechanism: Myomas, or uterine fibroids, are benign tumors that can alter uterine structure and function. They may contribute to abnormal uterine contractions or bleeding, potentially increasing the risk of pregnancy complications, including abortion.

• Key complication: While minor, the presence of multiple myomas can lead to increased bleeding during the abortion process, necessitating careful monitoring to manage hemodynamic stability and prevent excessive blood loss.

Patient Profile

Demographics:

32-year-old female, office manager

History:

• Key past medical history: G1P1 (1001) complete abortion, diagnosed with multiple uterine myomas

• Current medications: Oral contraceptives

• Allergies: None known

Current Presentation:

• Chief complaint: Mild pelvic discomfort

• Key symptoms: Occasional spotting, mild cramping

• Vital signs: Blood pressure 118/76 mmHg, heart rate 72 bpm, respiratory rate 16 breaths per minute, temperature 98.6°F

Section 1

Initial Assessment Findings:

During the initial assessment, the patient presents with stable vital signs, and her overall appearance is well-groomed, appropriate for her role as an office manager. Despite her mild pelvic discomfort, she is alert and oriented, maintaining good eye contact and responding appropriately to questions. The pelvic examination reveals a slightly enlarged, but non-tender uterus, consistent with the presence of myomas. There is no evidence of significant bleeding at this time, though occasional spotting is noted. Her abdomen is soft and non-distended, with no palpable masses other than the uterine enlargement.

The nurse reviews the patient's recent laboratory results, which show a hemoglobin level of 12.5 g/dL, indicating no significant anemia despite the mild bleeding episodes. The patient's complete blood count is otherwise within normal limits, and her electrolytes are stable, suggesting adequate hydration and nutrition. Given her stable condition, the nurse focuses on patient education regarding signs of excessive bleeding to watch for, the importance of follow-up appointments, and how to manage mild cramping with over-the-counter pain relief if needed.

The nurse documents the findings and communicates with the healthcare team to ensure a collaborative approach to the patient's care. Emphasis is placed on monitoring the patient’s symptoms closely and providing reassurance, while also preparing her for potential future interventions should her condition change. This thorough assessment sets the stage for ongoing management and highlights the importance of vigilance in the context of her medical history and current presentation.

Section 2

Following the initial assessment, the patient remains stable with vital signs within normal limits: blood pressure at 118/76 mmHg, heart rate at 78 beats per minute, respiratory rate at 16 breaths per minute, and a temperature of 98.6°F. She reports no significant increase in pelvic pain or discomfort, and her spotting remains minimal. However, during a routine follow-up visit, new diagnostic results from an ultrasound reveal that the myomas, although still small, have slightly increased in number and are now classified as multiple. This finding is consistent with her recent mild increase in spotting, though it remains non-threatening at this stage.

The nurse reviews the ultrasound report with the patient and explains the significance of these findings in simple terms. The patient is reassured that the current situation doesn't warrant any immediate invasive intervention, but she is advised to monitor for any changes such as increased bleeding or significant pain. The nurse emphasizes the importance of adhering to scheduled follow-up visits to closely monitor the myomas and any potential changes in her condition.

With these new diagnostic results, the healthcare team decides to schedule more frequent monitoring, including regular ultrasounds, to ensure the myomas do not lead to further complications. The nurse continues to educate the patient on lifestyle modifications that could help manage her symptoms, such as maintaining a healthy diet and managing stress, and discusses the potential need for medication in the future if her symptoms worsen. This proactive approach aims to maintain her stable condition while preparing her for any necessary adjustments in her care plan.

Section 3

During a subsequent follow-up appointment, the patient reports experiencing a mild increase in pelvic pressure, which she describes as a sensation of fullness rather than pain. Her vital signs remain stable, with a blood pressure of 120/78 mmHg, heart rate of 80 beats per minute, respiratory rate of 16 breaths per minute, and temperature of 98.7°F. Upon physical examination, the nurse notes no significant tenderness upon palpation of the abdomen. The patient’s hemoglobin and hematocrit levels are slightly lower than her previous values, though they still fall within the normal range, suggesting that the increased spotting has not significantly affected her overall blood volume.

The healthcare team decides to conduct another ultrasound to further evaluate the status of the myomas. The results confirm a slight increase in the size of one of the myomas, although it remains small and not obstructive. The nurse discusses these findings with the patient, reiterating the importance of continued monitoring and explaining that while the changes are minor, they underscore the need for vigilance. The patient is reassured that her condition remains stable and that the proactive measures currently in place are designed to prevent any escalation.

In response to the new findings, the patient is encouraged to maintain a symptom diary, documenting any changes in her menstrual cycle, pain levels, or spotting. The nurse provides guidance on identifying potential warning signs that would necessitate immediate medical attention, such as severe pain or heavy bleeding. This collaborative approach empowers the patient to take an active role in her care, ensuring that she is well-informed and prepared for any potential changes in her condition. As the patient prepares for her next scheduled visit, she expresses confidence in the care plan and a commitment to adhering to the recommended lifestyle modifications and follow-up schedule.

Section 4

Two weeks later, the patient returns for her scheduled follow-up visit. During the initial assessment, she reports that the sensation of fullness has persisted, although it has not worsened. She also notes an increase in the frequency of her spotting but describes it as light. Her menstrual cycle has remained regular, and she denies experiencing any new symptoms such as severe pain or heavy bleeding. The patient’s vital signs are recorded: blood pressure is 118/76 mmHg, heart rate is 82 beats per minute, respiratory rate is 16 breaths per minute, and temperature is 98.6°F, all indicating a stable condition.

The nurse conducts a comprehensive physical examination, which reveals no new areas of abdominal tenderness or palpable masses. The patient’s symptom diary is reviewed, and the nurse notes the consistency in the reported symptoms, supporting the clinical findings of stability. The patient’s hemoglobin and hematocrit levels are rechecked; while there is a slight downward trend compared to previous measurements, they remain within the normal range, confirming that the spotting has not resulted in significant blood loss.

Given these findings, the healthcare team decides to continue with the current management plan, emphasizing the importance of regular monitoring and lifestyle modifications to mitigate any potential complications from the myomas. The patient is advised to maintain her symptom diary and to promptly report any significant changes, such as increased bleeding or pain. With the patient expressing understanding and commitment to the care plan, the nurse schedules the next follow-up appointment, ensuring continuity of care and reinforcing the collaborative approach in managing her condition.

Section 5

Two weeks after the last follow-up, the patient returns to the clinic reporting a new development: she has been experiencing intermittent lower abdominal discomfort, which she describes as a mild cramping sensation. She mentions that the sensation of fullness has slightly increased but remains manageable. Her spotting continues at a light level, and her menstrual cycle is still regular. Vital signs are once again stable, with a blood pressure of 120/78 mmHg, heart rate of 80 beats per minute, respiratory rate of 16 breaths per minute, and temperature of 98.7°F.

During this visit, a pelvic ultrasound is performed to reassess the status of her myomas. The results indicate that while the myomas have not significantly increased in size, there is a slight change in their positioning, which could account for the increased sensation of fullness and mild cramping. The hemoglobin and hematocrit levels are checked again, showing a slight decline but still within normal limits, indicating that the spotting continues to have a minimal impact on her overall blood volume and health status.

Acknowledging these findings, the healthcare team decides to introduce a conservative intervention aimed at symptom relief, such as recommending nonsteroidal anti-inflammatory drugs (NSAIDs) for the cramping, and continues encouraging lifestyle modifications including dietary adjustments and regular physical activity. The patient is reminded of the importance of adhering to these recommendations and maintaining her symptom diary. She is instructed to watch for any signs of increased pain, heavier bleeding, or other new symptoms, and to report them promptly. The nurse schedules another follow-up appointment, ensuring that close monitoring and supportive care remain in place as the patient's condition evolves.